Envista Holdings Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
$NVST
Medical/Dental Instruments
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________________
FORM 8-K
_____________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): June 10, 2025
_____________________________________________
(Exact Name of Registrant as Specified in Its Charter)
_____________________________________________
(State or Other Jurisdiction of Incorporation)
| (Commission File Number) | (IRS Employer Identification No.) | ||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||
(714 ) 817-7000
(Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
_____________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On June 10, 2025, the Company held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the following proposals:
Proposal 1- Election of Directors
The Company’s stockholders elected the persons listed below as Directors for a one-year term expiring at the Company’s 2026 annual meeting of stockholders and until his or her successor is elected and qualified by the following votes:
| Nominee | Votes For | Votes Withheld | Broker Non-Votes | |||||||||||||||||
| Paul Keel | 163,391,468 | 303,313 | 2,120,352 | |||||||||||||||||
| Wendy Carruthers | 161,339,489 | 2,355,292 | 2,120,352 | |||||||||||||||||
| Kieran Gallahue | 162,418,879 | 1,275,902 | 2,120,352 | |||||||||||||||||
| Scott Huennekens | 153,111,918 | 10,582,863 | 2,120,352 | |||||||||||||||||
| Barbara Hulit | 163,383,476 | 311,305 | 2,120,352 | |||||||||||||||||
| Vivek Jain | 163,385,313 | 309,468 | 2,120,352 | |||||||||||||||||
| Daniel Raskas | 162,445,421 | 1,249,360 | 2,120,352 | |||||||||||||||||
| Christine Tsingos | 162,445,708 | 1,249,073 | 2,120,352 | |||||||||||||||||
Proposal 2 - Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accountant
To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025. The proposal was approved by a vote of stockholders as follows:
| Votes For | Votes Against | Votes Abstained | Broker Non-Votes | |||||||||||||||||
| 165,698,453 | 46,138 | 70,542 | — | |||||||||||||||||
Proposal 3 - Advisory Vote to Approve Executive Compensation
To approve on an advisory basis the Company’s named executive officer compensation. The proposal was approved by a vote of stockholders as follows:
| Votes For | Votes Against | Votes Abstained | Broker Non-Votes | |||||||||||||||||
| 154,290,359 | 9,339,610 | 64,812 | 2,120,352 | |||||||||||||||||
Proposal 4 - Approval of an Amendment to the Company's Omnibus Incentive Plan
To approve an amendment to the Company’s Omnibus Incentive Plan, as amended, to increase the number of shares authorized for issuance under the plan by 6,425,000 shares:
| Votes For | Votes Against | Votes Abstained | Broker Non-Votes | |||||||||||||||||
| 154,113,806 | 9,487,296 | 93,679 | 2,120,352 | |||||||||||||||||
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits.
| Exhibit No. | Description | |||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ENVISTA HOLDINGS CORPORATION | ||||||||
| Date: June 12, 2025 | By: | /s/ Mark Nance | ||||||
| Mark Nance | ||||||||
| Senior Vice President, General Counsel and Secretary | ||||||||